We reported CD24 amplification in carcinoma of breast, ovarian, lung but not in the prostate, and the copy number amplification was strongly correlated with CD24 mRNA overexpression, which in turn correlated with signature genes of tumor growth and metastasis. This evidence concerns the gene CD24 and carcinoma.